Can prior microbial immune stimulation produce cross-reactive neural antibodies, while isolated IgG still points to past exposure?

At age 78, interpreting serology in clinical context is particularly important: persistent IgG is common after remote exposure and should not be equated with an ongoing infectious or neuroimmune process.

Clinical and serologic evidence

• IgG-positive, IgM-negative results with no PCR detection support prior immune exposure, not active infection. For toxoplasmosis, this pattern generally indicates infection acquired ≥6 months earlier; IgG can persist for years. For EBV, VCA/EBNA IgG with negative VCA IgM is the typical past-infection pattern, and antibodies often persist lifelong.
• Lyme guidance similarly recognizes that antibodies may remain detectable after prior infection; a positive antibody test alone does not diagnose active disease.
• Negative PCR and absent IgM do not absolutely exclude active infection, because sensitivity varies with pathogen, illness stage, and specimen. However, they do not make isolated IgG evidence for active infection.

Molecular mimicry and neural effects

• Defined human neuroimmune disorders support microbial molecular mimicry as a biologically plausible, pathogen-specific mechanism. In Sydenham chorea, streptococcal-associated antibodies recognize lysoganglioside, tubulin, and dopamine receptors and can increase neuronal CaMKII signaling.
• In HTLV-1–associated myelopathy/tropical spastic paraparesis, antibodies to viral Tax cross-react with neuronal hnRNP-A1; patient IgG bound neurons and inhibited neuronal firing in experimental brain preparations.
• Neural cross-reactivity alone does not establish that antibodies cause symptoms. Clinical relevance depends on access to neural tissue, target engagement, and demonstrable functional effects.

Bottom line

• The claim is supported: remote or persistent microbial immune stimulation can, in particular pathogen–disease settings, produce cross-reactive neural antibodies; but isolated IgG without IgM or PCR evidence indicates prior immune exposure and is insufficient by itself to establish an active infection or a causal explanation for neurologic symptoms.